Gerresheimer (GXI GY) completes the sale of Centor for EUR 1.5bln

For Gerresheimer the mechanism runs through the balance sheet: divestment proceeds of this scale relative to the group's size have historically been deployed first against leverage, with any remainder read as capacity for buybacks or reinvestment, and the market read tends to hinge on what management signals about allocation on the next call. The strategic pattern for packaging names selling a non-core unit is margin and mix optics; shedding a plastics or closures business changes the peer comparison toward pure-play glass and pharma packaging, which is where the multiple debate usually moves after completion. Worth noting is whether proceeds arrive in cash at completion as stated or carry deferred or earn-out elements, since that determines how quickly net debt actually falls. Follow-ons are the updated leverage guidance, any commentary on the remaining portfolio, and whether the buyer's identity draws integration or antitrust noise on its side. The deal having reached completion removes the residual execution risk that typically keeps a small discount in the shares between signing and close.